|Daily Range||$1.76 - $1.81|
|52-Week Range||$1.65 - $3.18|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,148,670|
|Current FY EPS||-$0.16|
Lexicon Pharmaceuticals, Inc. (LXRX) Description
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexicon-genetics.com/
News & Commentary
Lexicon Pharmaceuticals will focus its efforts on late-stage drug development, which will lead to the loss of 115 jobs.
Neurocrine Biosciences isn't up nearly as much as it appears.
Do these fallen angels deserve a second chance? You be the judge!
These three biotechs have the potential to beat the broader market in 2014.
How poorly did Lexicon, Orexigen, and Ariad stocks perform this week? Bad enough to be the three worst health-care stocks in the land.